BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10498626)

  • 1. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
    Storb R; Yu C; Zaucha JM; Deeg HJ; Georges G; Kiem HP; Nash RA; McSweeney PA; Wagner JL
    Blood; 1999 Oct; 94(7):2523-9. PubMed ID: 10498626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
    Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
    Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
    Storb R; Yu C; Barnett T; Wagner JL; Deeg HJ; Nash RA; Kiem HP; McSweeney P; Seidel K; Georges G; Zaucha JM
    Blood; 1999 Aug; 94(3):1131-6. PubMed ID: 10419907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
    Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R
    Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
    Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
    Zaucha JM; Zellmer E; Georges G; Little MT; Storb R; Storer B; Torok-Storb B
    Biol Blood Marrow Transplant; 2001; 7(11):613-9. PubMed ID: 11760149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation.
    Panse JP; Storb R; Storer B; Santos EB; Wentzel C; Sandmaier BM
    Transplantation; 2005 Nov; 80(10):1518-21. PubMed ID: 16340800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
    Jochum C; Beste M; Zellmer E; Graves SS; Storb R
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):164-71. PubMed ID: 17241922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.
    Lee WS; Suzuki Y; Graves SS; Iwata M; Venkataraman GM; Mielcarek M; Peterson LJ; Ikehara S; Torok-Storb B; Storb R
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):465-75. PubMed ID: 20457265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism.
    Li S; Thanikachalam M; Pang M; Carreno M; Aitouche A; Pham SM
    Exp Hematol; 2001 Apr; 29(4):534-41. PubMed ID: 11301194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
    Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
    Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.
    Sandmaier BM; Fukuda T; Gooley T; Yu C; Santos EB; Storb R
    Exp Hematol; 2003 Feb; 31(2):168-75. PubMed ID: 12591282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation.
    Bethge WA; Wilbur DS; Storb R; Hamlin DK; Santos EB; Brechbiel MW; Fisher DR; Sandmaier BM
    Blood; 2003 Jun; 101(12):5068-75. PubMed ID: 12609833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.
    Sorror ML; Leisenring W; Mielcarek M; Baron F; Diaconescu R; Hogan WJ; Graves SS; Storb R
    Transplantation; 2008 Apr; 85(7):1023-9. PubMed ID: 18408584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmyeloablative transplants: preclinical and clinical results.
    Sandmaier BM; McSweeney P; Yu C; Storb R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):78-81. PubMed ID: 10877058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.
    Hogan WJ; Little MT; Zellmer E; Friedetzky A; Diaconescu R; Gisburne S; Lee R; Kuhr C; Storb R
    Biol Blood Marrow Transplant; 2003 Aug; 9(8):489-95. PubMed ID: 12931117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model.
    Lange S; Altmann S; Brandt B; Adam C; Riebau F; Vogel H; Weirich V; Hilgendorf I; Storb R; Freund M; Junghanss C
    Exp Hematol; 2009 Jan; 37(1):143-50. PubMed ID: 19100524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
    Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
    Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.